Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update is a research paper published in Clinical Pharmacology & Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 173 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R24 GM061374
NIGMS NIH HHS
Grant: R24 GM123930
NHLBI NIH HHS
Grant: U01 HL105198
NIGMS NIH HHS
Grant: U01 GM092666
NIGMS NIH HHS
Grant: P01 GM032165
NHGRI NIH HHS
Grant: R01 HG010863
NHGRI NIH HHS
Grant: U24 HG010135
NHLBI NIH HHS
Grant: K01 HL143137
NIGMS NIH HHS
Grant: P50 GM115305
NIAID NIH HHS
Grant: R21 AI139021
NIGMS NIH HHS
Grant: R24 GM115264
NIGMS NIH HHS
Grant: U01 GM092676
NIAID NIH HHS
Grant: R34 AI136815
FWCI
15.40
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Intranasal delivery of phenytoin loaded layered double hydroxide nanoparticles improves therapeutic effect on epileptic seizures
Additional file 1 of Intranasal delivery of phenytoin loaded layered double hydroxide nanoparticles improves therapeutic effect on epileptic seizures